Source: www.aapm.org

July 23, 2007 - Using innovative physics, researchers have proposed a system that may one day bring proton therapy, a state-of-the-art cancer treatment method currently available only at a handful of centers, to radiation treatment centers and cancer patients everywhere. Compared to the x rays conventionally used in radiation therapy, protons are potentially more effective, as they can deposit more cell-killing energy in their tumor targets and less in surrounding healthy tissue. However, to kill tumors, the protons must be accelerated to sufficiently high energies, which currently must be achieved in large, expensive devices called cyclotrons or synchrocyclotrons that cost hundreds of millions of dollars and occupy a room the size of basketball courts.

Thomas Mackie, a professor at the University of Wisconsin and co-founder of the radiation therapy company TomoTherapy, will present a proton-therapy design based on a much smaller device known as a "dielectric wall accelerator" (DWA). Currently being built as a prototype at Lawrence Livermore National Laboratory, the DWA can accelerate protons to up to 100 million electron volts in just a meter. A two-meter DWA could potentially supply protons of sufficiently high energy to treat all tumors, including those buried deep in the body, while fitting in a conventional radiation treatment room.
The DWA is a hollow tube whose walls consist of a very good insulator (a dielectric). When most of the air is removed from the tube to create a vacuum, the tube can structurally withstand the very high electric-field gradations necessary for accelerating protons to high energies in a short distance.
In addition to its smaller size, a DWA-based proton therapy system would have another benefit—it could vary both proton energy and proton-beam intensity, two variables that cannot both be adjusted at the same time in existing proton-treatment facilities. This capability could lead to "intensity-modulated proton therapy" (IMPT), the proton version of the x-ray-based intensity modulated radiation therapy (IMRT) technique which has become a popular method for delivering precise radiation doses to the parts of a tumor. Mackie cautions that clinical trials of the system are at least five years away. But if the DWA approach proves feasible, protons may eventually represent a widespread, rather than limited, option for treating cancer.

For more information: www.aapm.org, www.llnl.gov, www.wisc.edu


Related Content

Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

August 30, 2023 — A published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children ...

Time August 30, 2023
arrow
News | Radiation Therapy

August 17, 2023 — A 67-year old patient presenting with oesophageal cancer was treated at the Paul Scherrer Institute ...

Time August 17, 2023
arrow
News | Radiation Therapy

August 3, 2023 —RaySearch Laboratories AB announced that Lausanne University Hospital (CHUV), Switzerland, has treated ...

Time August 03, 2023
arrow
Feature | Radiation Therapy | By Vinisha Joshi

The rising prevalence of cancers calls for a diverse set of treatment services. According to the American Cancer Society ...

Time July 11, 2023
arrow
News | Radiation Therapy

June 12, 2023 — Cancer that spreads to the brain from another part of the body such as lung or breast is called a ...

Time June 12, 2023
arrow
News | Radiology Business

June 6, 2023 — RaySearch Laboratories has announced that New York University (NYU) Langone Hospital - Long Island ...

Time June 06, 2023
arrow
News | Radiation Oncology

April 28, 2023 — Elekta Esprit, a high precision stereotactic radiosurgery device, used to treat targets in the brain ...

Time April 27, 2023
arrow
News | Proton Therapy

April 3, 2023 — P-Cure announced clearance of its Adaptive Proton Therapy Solution by the FDA for sales in the USA. P ...

Time April 03, 2023
arrow
Subscribe Now